Clinical Trials on Ultrafiltration Failure in Liechtenstein
Total 1 results
-
Ivoclar Vivadent AGActive, not recruitingDental Prosthesis Failure | Edentulous MouthLiechtenstein
Sponsors and Collaborators
- Center for Rare Neurological Diseases, Norcross, GA
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Manmohan Cardiothoracic Vascular and Transplant Center
- Gulsah Ilhan
- Ana Paula Costella
- HeartPoint Global
- King Baudouin Foundation
- Pharmaspecific
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Frankel, Amylynne, M.D.
- IRCCS Don Gnocchi, Milano, Italy
- Fundación Pública Andaluza Progreso y Salud
- Ruba Musharbash Nutrition Consultancy Center
- Michael J. Wesley, PhD
- Army Hospital, Percy
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Walgreens Co.
- Edanz Group Japan Ltd
- Laboratorios Viñas, S.A.
- Korrus Inc.
- View Full List
Medical Conditions
- Impairment, Coordination
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Lung Neuroendocrine Tumor
- Cardiovascular Outcomes
- Coagulation Disorder Neonatal
- Kidney Damage
- Cognitive Function, Social 1
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Ankylosed Teeth
- Pelvis Tumors
- Gastroenteritis Rotavirus
- Paralysis of Vocal Cords or Larynx
- Severe Atopic Dermatitis
- Malignant Intracranial Germ Cell Tumor
- Localized Unresectable Adult Primary Liver Cancer
- Uncontrolled Type 2 Diabetes Mellitus
- Facial Involvement
- Developmental Language Disorder and Language Impairment
- Menopause
- Brain Arteriovenous Malformation
- View Full List
Drug Interventions
- Dexmedetomidine
- Extended release guanfacine
- Methotrexate
- 5-Fluorouracil
- Transdermal estradiol
- Ozanimod
- Rituximab plus CHOP
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Interferon beta-1b (Betaferon, BAY86-5046)
- Miglustat
- Apremilast
- Insulin
- FHND5071
- LDEPA
- CD25 treatment
- Thiotepa
- Interleukin-2
- Exendin 9-39
- Lidocaine/ ketamine
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Colombia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Ukraine
- Contract Research Organizations in United Kingdom
- CRO list by country